Functionally, CD39-generated adenosine inhibits effector T cell activation, while PD-1 signaling enhances Treg survival and suppressive function, collectively establishing a systemically immunosuppressive phenotype that contributes to tumor immune evasion (8, 9). The gene discussed is PDCD1; the disease is neoplasm.